BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Amazon
AMZN
|
+$839M |
| 2 |
Industrial Select Sector SPDR Fund
XLI
|
+$331M |
| 3 |
Visa
V
|
+$314M |
| 4 |
Apple
AAPL
|
+$297M |
| 5 |
Broadcom
AVGO
|
+$287M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
+$595M |
| 2 |
Technology Select Sector SPDR Fund
XLK
|
+$362M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$250M |
| 4 |
DuPont de Nemours
DD
|
+$208M |
| 5 |
SPDR S&P Biotech ETF
XBI
|
+$198M |
Sector Composition
| 1 | Technology | 23.99% |
| 2 | Consumer Discretionary | 11.98% |
| 3 | Healthcare | 10.54% |
| 4 | Financials | 9.96% |
| 5 | Industrials | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Cue Biopharma
CUE
$58.8M
| $44.2K | ﹤0.01% |
16,724
-4,972
| -23% | -$13.1K |
|
|
SBT
2752
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $43.8K | ﹤0.01% |
7,595
-2,625
| -26% | -$15.1K |
|
2753
NACCO Industries
NC
$306M
| $43.7K | ﹤0.01% |
1,198
-566
| -32% | -$20.7K |
|
2754
iShares Core MSCI Europe ETF
IEUR
$6.94B
| $43.4K | ﹤0.01% |
789
-131,810
| -99% | -$7.25M |
|
2755
Bank7 Corp
BSVN
$464M
| $43.3K | ﹤0.01% |
1,584
-403
| -20% | -$11K |
|
|
BHR
2756
Braemar Hotels & Resorts
BHR
$205M
| $43.3K | ﹤0.01% |
17,321
-51,823
| -75% | -$130K |
|
2757
Angi Inc
ANGI
$797M
| $42.7K | ﹤0.01% |
1,716
+1,582
| +1,181% | +$39.4K |
|
2758
Xoma
XOMA
$456M
| $42.1K | ﹤0.01% |
2,277
+1,234
| +118% | +$22.8K |
|
2759
Woodside Energy
WDS
$31.6B
| $40.9K | ﹤0.01% |
1,938
+1,937
| +193,700% | +$40.9K |
|
|
CLPR
2760
Clipper Realty
CLPR
$70.6M
| $40.8K | ﹤0.01% |
7,560
-23,634
| -76% | -$128K |
|
|
MACK
2761
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $40.7K | ﹤0.01% |
3,034
+1,495
| +97% | +$20K |
|
2762
Lands' End
LE
$467M
| $40.6K | ﹤0.01% |
4,242
-14,871
| -78% | -$142K |
|
2763
Stoke Therapeutics
STOK
$1.31B
| $40.5K | ﹤0.01% |
7,694
-20,458
| -73% | -$108K |
|
|
VRNA
2764
Verona Pharma
VRNA
$9.2B
| $40.3K | ﹤0.01% |
2,028
+1,128
| +125% | +$22.4K |
|
2765
Equinor
EQNR
$61.1B
| $40.2K | ﹤0.01% |
1,271
+507
| +66% | +$16K |
|
2766
Veritone
VERI
$195M
| $39.8K | ﹤0.01% |
22,009
+17,560
| +395% | +$31.8K |
|
2767
Bankwell Financial Group
BWFG
$352M
| $39.8K | ﹤0.01% |
1,319
-1,123
| -46% | -$33.9K |
|
2768
DiaMedica Therapeutics
DMAC
$376M
| $39.8K | ﹤0.01% |
14,000
| – | – |
|
2769
Goldman Sachs BDC
GSBD
$1.3B
| $39.4K | ﹤0.01% |
2,689
-8,023
| -75% | -$118K |
|
|
AVDL
2770
Avadel Pharmaceuticals
AVDL
$1.54B
| $39.3K | ﹤0.01% |
2,784
+1,625
| +140% | +$22.9K |
|
2771
Maui Land & Pineapple Co
MLP
$370M
| $39K | ﹤0.01% |
2,455
+1,349
| +122% | +$21.4K |
|
2772
iShares ESG Aware MSCI EM ETF
ESGE
$5.34B
| $38.2K | ﹤0.01% |
1,193
+603
| +102% | +$19.3K |
|
2773
Petrobras Class A
PBR.A
$75.1B
| $38K | ﹤0.01% |
2,488
+128
| +5% | +$1.96K |
|
2774
Arm
ARM
$164B
| $37.6K | ﹤0.01% |
+500
| New | +$37.6K |
|
2775
Security National Financial
SNFCA
$237M
| $35.4K | ﹤0.01% |
4,339
-13,621
| -76% | -$111K |
|